Login
Login     |     Register     |     Recover Username/Password

General Investing

Transocean LTD (RIG) Sees Potential Stock Upside in Coming Years After Macondo Issues

March 04, 2013

Analysts describe a potentially more positive future for Transocean LTD (RIG) stock after the Macondo oil spill in the Gulf of Mexico in 2010, citing improved operational procedures and the name trading at a discount:

“We like Transocean. It’s coming off of a hangover of sorts from Macondo and from some issues in Brazil. With the impact from Macondo becoming clearer and the liabilities slowly getting settled, Transocean is attractive. It’s traded at a discount to its peers recently, and historically it has traded at a premium,” said Trey Stolz, Managing Director of Oilfield Services Research at IBERIA Capital Partners.

The stock has also attracted the attention of activist investors:

“First, Carl Icahn got involved in Transocean early this year. Even though it was widely viewed as an undervalued name, I think Carl Icahn getting involved really brought the story to the fore again. I believe that it is a company that really did a great job re-engineering itself following Macondo. They launched a number of internal initiatives to address some of their shortfalls in procedures, and they are upgrading the whole infrastructure of the company. After about 18 months of that, I think that 2013 and 2014 will be very bright for Transocean, because a number of those initiatives should provide benefits in the upcoming years. I think that may be one of the many reasons why Mr. Icahn got involved in the name,” said Nigel Browne, Equity Research Analyst at Macquarie Capital.

Finally, they also mention RIG‘s cash return strategies:

“There are other companies such as Ensco, Transocean and Noble, which are in the process of returning more cash,” said Scott Gruber, Senior Research Analyst at Sanford C. Bernstein & Co., LLC.

FORE MORE INFORMATION ABOUT THESE INTERVIEWS CLICK HERE.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now